📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Peptide modified mesenchymal stem cells as targeting delivery system transfected with miR-133b for the treatment of cerebral ischemia. (2017)

First Author: Huang B

Attributed to: Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ijpharm.2017.08.073

PubMed Identifier: 28827201

Publication URI: http://europepmc.org/abstract/MED/28827201

Type: Journal Article/Review

Volume: 531

Parent Publication: International journal of pharmaceutics

Issue: 1

ISSN: 0378-5173